Provided by Tiger Fintech (Singapore) Pte. Ltd.

X4 Pharmaceuticals Inc

3.56
-0.5800-14.01%
Post-market: 3.610.0500+1.40%19:59 EDT
Volume:2.09M
Turnover:8.93M
Market Cap:20.61M
PE:1.65
High:4.20
Open:4.17
Low:3.53
Close:4.14
Loading ...
Aug 17, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 04, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2020

Major Issues Report

8-K - Current report
Jun 11, 2020

Major Issues Report

8-K - Current report
Jun 10, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 07, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 07, 2020

Major Issues Report

Current report, item 2.02
Mar 20, 2020

Major Issues Report

Current report, item 5.02
Mar 17, 2020

Major Issues Report

Current report, items 1.01 and 2.03
Mar 13, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Mar 12, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2020

Major Issues Report

Current report, item 2.02
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Major Issues Report

Current report, item 5.02
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 10, 2020

Major Issues Report

Current report, items 2.02, 7.01, 8.01, and 9.01
Dec 17, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals